ArticleLeukemia2023

Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias.

Eugene Nikitin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.